Literature DB >> 19999225

MUC1 based breast cancer vaccines: role of post translational modifications.

Mumtaz Begum1, Rukhshan Khurshid, Asmat Saleem, Saeed Ahmed Nagra.   

Abstract

BACKGROUND: Vaccine development is one of the most promising fields in cancer research. After autologous transplantation, due to low tumour burden, patients are more likely to respond immunologically to a cancer vaccine. MUC1 with its adhesive and antiadhesive functions, immunostimulatory and immunosuppressive activities, is therefore a good candidate for breast cancer vaccine. A structure-based insight into the immunogenicity of natural MUC1 glycoforms, of its sub-domains, motifs and post translational modification like glycosylation and myriostoylation may aid the design of tumour vaccines.
METHODS: Primary sequences of human MUC1 were retrieved from the SWISSPROT data bank. Protein pattern search: The primary sequence of Human MUC1 was searched at PROSITE (a dictionary of protein sites and patterns) database.
RESULTS: Our study observes that post-translational modifications play an important role in presenting MUC1 as a candidate for breast cancer vaccine.
CONCLUSION: It is found that the phosphrylation and glycosylation of important functional motifs of MUC1 may take part in the production of cytokines that may provide immunization.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19999225

Source DB:  PubMed          Journal:  J Ayub Med Coll Abbottabad        ISSN: 1025-9589


  1 in total

1.  Management of breast cancer by vaccine: fact or fiction.

Authors:  Soumen Das; Retina Paul; Utpal De; Mrityunjay Mukherjee
Journal:  J IMA       Date:  2013-04-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.